Indian angel investment platform Inflection Point Ventures (IPV) has secured 14 exits in 2024, delivering a 36% internal rate of return (IRR).
Despite a slowdown in venture capital markets, IPV's portfolio startups continue to attract investors, with 25 securing follow-on funding rounds in 2024.
Aksum, Conscious Chemist, and Qubehealth were among the successful exits, offering IRRs ranging from 52% to 54%.
Notably, IPV-backed startups have also been acquired by companies like IBM and CrashPlan, yielding attractive IRRs and returns.